What are the most reputable compounded GLP-1 programs right now?

Short answer up front: if you’re considering a compounded GLP‑1 (e.g., semaglutide/tirzepatide) pick a compounding pharmacy that is PCAB‑accredited or an FDA‑registered 503B outsourcing facility, publishes Certificates of Analysis (CoAs), follows USP <797>/<800> sterile standards, and offers cold‑chain shipping. Commonly recommended names to start with (verify current services and product availability) are:

• Wedgewood Pharmacy (Wedgewood Village/Wedgewood Compounding) — well known for sterile compounding and peptide work; generally PCAB‑accredited and used by many prescribers for injectable compounds.
• Empower Pharmacy — large national compounding pharmacy with a history of sterile injectable/peptide compounding and physician-facing services; offers COAs and patient/clinic support.
• Fagron (Fagron Sterile Services / Fagron 503B) — global compounding supplier with 503B outsourcing facilities in the U.S.; strong manufacturing/QC infrastructure and widely used by clinics.
• PCCA‑affiliated compounding pharmacies — PCCA (Pharmaceutical Compounding Centers of America) isn’t a pharmacy itself but its member pharmacies receive training, validated formulations and quality guidance; searching for a local PCCA member can find reputable 503A compounding partners.

Why these names: they are widely used by clinicians, have established sterile compounding operations, and (in many cases) formal accreditation/outsourcing‑facility status and QC processes that reduce—but do not eliminate—risk.

Important safety/legal points (please read before proceeding)

• FDA‑approved GLP‑1 products (Ozempic/Wegovy, Mounjaro/Zepbound, etc.) are the standard of care. Compounded GLP‑1s are not FDA‑approved and can vary in potency, sterility, and storage/handling.
• For sterile injectables you should prefer an FDA‑registered 503B outsourcing facility when possible because they are inspected by FDA and operate at a larger scale under stricter controls than many 503A pharmacies.
• Always require: physician prescription/oversight, CoAs for each lot (potency/purity/sterility), cold‑chain shipping and tracking, and clear patient counseling on dosing and disposal.
• Check your state board of pharmacy for pharmacy licensing/disciplinary history and look for PCAB accreditation status.

How to vet a specific program quickly

1. Ask for PCAB accreditation or 503B registration status and date of last inspection.
2. Request recent Certificates of Analysis (potency, sterility, endotoxin) for the exact product lot.
3. Confirm USP <797>/<800> compliance and cleanroom ISO class.
4. Verify cold‑chain shipping (insured overnight, temperature tracking) and return/refund policy.
5. Read independent reviews from clinics/physicians and check state board records.

Alternatives to compounded GLP‑1

• See if you qualify for a prescription of an FDA‑approved GLP‑1 through a local/endocrinology clinic or telehealth service (often safer and covered by insurance in some circumstances).
• Manufacturer savings programs or patient assistance for brand products.

If you want, tell me: (a) whether you’re in the U.S., (b) whether you prefer a mail‑order national pharmacy or a local compounding pharmacy, and (c) whether you’re looking for semaglutide or tirzepatide — I can look up current local options and give a more tailored shortlist and vetting checklist.